Search Results

The Pipeline

The Paul Glaucoma Implant

Improving the safety and efficacy of tube shunt surgery.

Chelvin Sng, BA, MA, MBBChir, MMed, MRCS(Ed), FRCS(Ed), FAMS

Cover Focus

Evolutions in Patient Selection

Glaucoma specialists reflect on surgical practices that have and have not changed in recent years.

Paul Harasymowycz, MD; Hady Saheb, MD, MPH, FRCSC; Shivani Kamat, MD; Anup K. Khatana, MD; Pradeep Ramulu, MD, PhD; Chelvin Sng, MBBChir, MA, MMed, FRCS(Ed); Benjamin Y. Xu, MD, PhD; and Douglas J. Rhee, MD

The Pipeline

The Eyewatch System

A new avenue for greater IOP control.

Karl Mercieca, MD, PGCME, FRCOphth, FEBOS-GL

Cover Focus

At-Home Tools for the Glaucoma Patient

Current and future solutions may facilitate disease monitoring and management.

Yvonne Ou, MD

The Literature

Cost Considerations in Glaucoma Care

Assessing the costs associated with the medical and surgical management of the disease.

Thomas E. Bournias, MD, and Mark M. Rzadkowski, MD

Peer Review

Safety and Efficacy Outcomes of Low-Cost Glaucoma Drainage Implants

Two novel devices expand the options for surgical glaucoma treatment on a global level.

Ahmad A. Aref, MD, MBA

Research Results

Therapeutically Targeting Disease in Glaucoma

New findings of glaucomatous changes in Schlemm canal cells point to the possibility of directing treatment to restore the function of diseased outflow tissue.

Mark Johnson, PhD, and W. Daniel Stamer, PhD

Research Results

Therapeutically Targeting Disease in Glaucoma

New findings of glaucomatous changes in Schlemm canal cells point to the possibility of directing treatment to restore the function of diseased outflow tissue.

Mark Johnson, PhD, and W. Daniel Stamer, PhD

Challenging Cases

Iridoschisis and Glaucoma

JOHN MARK S. DE LEON, MD, AND ROLAN A. MANGAHAS, MD